There is a difference between finding an attractive market and finding a problem you cannot stop thinking about.
For Derik Fay, GLP-1 healthcare became the latter.
Fay had already spent more than two decades building, investing in and exiting businesses by the time he stepped away from day-to-day operating. Through 3F Management, which he founded in 2004, his business interests had stretched across fitness, financial services, payment processing, marketing, franchising, media, technology and home services.
After years in the founder’s seat, he deliberately changed vantage points.
For roughly five years, Fay focused more heavily on investments, mergers and acquisitions, corporate restructuring and advising executives at large organizations. Instead of waking up every morning responsible for one operating company, he spent his time evaluating businesses from the outside.
That changed his thinking.
Founders naturally obsess over sales, growth and momentum. Investors and buyers look at something different. They study recurring earnings, concentration risk, management depth, compliance, scalability and what happens to a company when its founder is no longer in the room.
Fay began to see those two perspectives as complementary.
Then GLP-1 medications exploded into public consciousness.
The obvious story was demand. Consumers wanted access to medications such as semaglutide and tirzepatide. Telehealth platforms multiplied. Pharmacies expanded. New companies appeared almost overnight.
Fay became interested in what was happening behind the visible growth.
Who was handling fulfillment?
Who was managing prescription routing?
How were companies navigating multiple states?
What did payment processors think of the category?
What would regulators demand as the market matured?
What would an institutional buyer eventually want to see?
Those questions drew him back into operating.
Today, Fay leads RX Management Systems, a healthcare management platform built around pharmacy operations, fulfillment, compliance, strategic growth, partnerships and acquisitions.
The decision is notable because Fay did not return to entrepreneurship by simply starting another consumer brand.
He returned with a different objective.
He wanted to build infrastructure.
That idea reflects a philosophy Fay has used throughout his career, something he describes as “dirt to exit.” Instead of building a company around the opportunity immediately in front of him, he prefers to begin with the enterprise the company may eventually need to become.
The distinction matters in healthcare.
A pharmacy can generate revenue.
A management platform capable of coordinating pharmacies, fulfillment, compliance, acquisitions and recurring services may create a different type of enterprise.
That is the wager behind RX Management Systems.
The company operates alongside Believe RX, a Texas-based 503A compounding pharmacy, while Specialty Care oversees prescription fulfillment and operational logistics. RX Management Systems sits above those functions as the management layer responsible for growth, partnerships, compliance and acquisitions.
Fay’s interest is not limited to one medication.
That may ultimately be the most important part of the strategy.
Healthcare markets change quickly. Drugs rise and fall. Regulation moves. Consumer preferences shift. New therapies arrive.
Infrastructure has a longer life.
Fay believes the companies that endure will be the ones designed for the market after the current excitement fades.
That also explains his emphasis on compliance.
Fast-growing industries often reward speed early and discipline later. Fay is betting that healthcare will not give operators the luxury of separating those two things for long.
His approach has been to build regulatory and operational safeguards alongside growth, rather than waiting for oversight to force changes later.
That mindset comes directly from the years he spent studying companies from the perspective of investors, boards and buyers.
Once you have watched enough transactions, the weaknesses become predictable.
A company can be growing and still be difficult to acquire.
It can produce revenue and still lack enterprise value.
It can dominate a trend and still disappear when the trend changes.
Fay does not want RX Management Systems built that way.
One of the clearer examples from his earlier career is Around the Clock Fitness, the 24-hour health club company he founded in 2006. It grew into one of Florida’s largest independently owned fitness brands before being acquired by a publicly traded company in 2019.
Instead of viewing that exit as the finish line, Fay appears to have treated it as another education.
He spent the following years learning how sophisticated organizations evaluate risk, structure acquisitions and prepare companies for scale.
Now he is applying those lessons to healthcare.
The result is a second act that looks different from the first.
Earlier in his career, Fay built companies by learning industries from the ground up.
This time, he returned with the perspective of someone who has already been the founder, investor, adviser and seller.
GLP-1 may have been the catalyst.
But Fay’s larger bet is that the real company will be built around everything the market eventually requires after the excitement becomes an industry.
